Biotech · Private company · Birmingham, AL, US

Alveolus Bio, Inc.

Track this companyFree. Adds Alveolus Bio, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials0None registered

Pipeline programs0None found yet

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

NIH awards4

An Inhaled Live Biotherapeutic for Influenza Viral InfectionFiscal year 2026 · $273.1KNIH RePORTER 1R43AI191900-01A1 · fetched Nov 12, 2026
Leveraging Live Biotherapeutics for the Treatment of Chronic RhinosinusitisFiscal year 2026 · $301.8KNIH RePORTER 1R43AI197548-01 · fetched Nov 12, 2026
An Inhaled Microbiome-Targeted Biotherapeutic for Treatment of COPDFiscal year 2025 · $992.4KNIH RePORTER 5R44HL164156-04 · fetched Nov 12, 2026
An Inhaled Microbiome-Targeted Biotherapeutic for Treatment of COPDFiscal year 2024 · $999.4KNIH RePORTER 4R44HL164156-03 · fetched Nov 12, 2026